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Abstract
During late April 2009, the first cases of 2009 pandemic influenza A (H1N1) (pH1N1) in Illinois were reported. On-going,
sustained local transmission resulted in an estimated 500,000 infected persons. We conducted a mixed method analysis
using both quantitative (surveillance) and qualitative (interview) data; surveillance data was used to analyze demographic
distribution of hospitalized cases and follow-up interview data was used to assess health seeking behavior. Invitations to
participate in a telephone interview were sent to 120 randomly selected Illinois residents that were hospitalized during
April–December 2009. During April–December 2009, 2,824 pH1N1 hospitalizations occurred in Illinois hospitals; median age
(interquartile range) at admission was 24 (range: 6–49) years. Hospitalization rates/100,000 persons for blacks and Hispanics,
regardless of age or sex were 2–3 times greater than for whites (blacks, 36/100,000 (95% Confidence Interval ([95% CI], 33–
39)); Hispanics, 35/100,000 [95%CI,32–37] (; whites, 13/100,000[95%CI, 12–14); p,0.001). Mortality rates were higher for
blacks (0.9/100,000; p,0.09) and Hispanics (1/100,000; p,0.04) when compared with the mortality rates for whites (0.6/
100,000). Of 33 interview respondents, 31 (94%) stated that they had heard of pH1N1 before being hospitalized, and 24
(73%) did not believed they were at risk for pH1N1. On average, respondents reported experiencing symptoms for 2 days
(range: 1–7) before seeking medical care. When asked how to prevent pH1N1 infection in the future, the most common
responses were getting vaccinated and practicing hand hygiene. Blacks and Hispanics in Illinois experienced
disproportionate pH1N1 hospitalization and mortality rates. Public health education and outreach efforts in preparation
for future influenza pandemics should include prevention messaging focused on perception of risk, and ensure community
wide access to prevention messages and practices.
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Introduction
During April 2009, the World Health Organization (WHO)
declared a ‘‘public health emergency of international concern’’ in
response to the first cases of infection with pandemic 2009
influenza A (H1N1) (pH1N1) in California and Mexico [1]. By
early June 2009, WHO declared a pandemic [2]. The first case of
pH1N1 infection in Illinois was reported April 25, 2009.
Laboratory-based surveillance data demonstrated that pH1N1
virus became the predominant circulating influenza virus in
Illinois within 2 weeks of its detection [3]. The novel virus, which
contain segments of avian, human, and swine origins, typically
caused mild disease [4] and it is estimated that on-going, sustained
local transmission resulted in an estimated 500,000 infected
persons [5].
Illinois was affected during both the spring (April–June 2009)
and fall (August–December 2009) pandemic waves. To better
understand the epidemiologic and clinical features of this
pandemic, the Illinois Department of Public Health (IDPH)
initiated enhanced surveillance for pH1N1 infection on April 25,
2009 by using the Illinois National Electronic Data Surveillance
System to collect clinical case data for hospitalizations and fatal
cases.
Study objectives were to 1) describe demographic and basic
clinical characteristics of persons hospitalized with pH1N1 and 2)
identify individual-level factors regarding health seeking behavior
amongst those hospitalized with pH1N1.
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Methods
Quantitative (Surveillance) Data
Illinois National Electronic Data Surveillance System (I-
NEDDS) data was entered by hospital infection control practi-
tioners and local health department staff. Data regarding Illinois
residents hospitalized with laboratory-confirmed pH1N1 during
April–December 2009 was extracted from I-NEDSS. A hospital
admission was defined as an overnight stay in an Illinois hospital
by an Illinois resident regardless of age. Laboratory confirmation
was defined as a positive result using any of the following
diagnostic measures: reverse-transcriptase polymerase chain reac-
tion (RT-PCR) test for the pH1N1 virus; an influenza A RT-PCR
test that was negative for human H1 and H3; a rapid influenza A
antigen test; direct immunofluorescence assay; or viral culture.
Each hospitalized patient was assigned a unique identifier. Race
and ethnicity were recorded as reported by hospitalized patients in
I-NEDSS; mortality was defined as a death during April–
December 2009 in a person in which pH1N1 was the leading or
a contributing cause of death.
High-risk medical co-morbidities, as defined by the Advisory
Committee on Immunization Practices, included chronic pulmo-
nary (including asthma), cardiovascular (excluding hypertension),
renal, hepatic, neurologic/neuromuscular, hematologic, and
metabolic disorders (including diabetes mellitus); immune sup-
pression, including immune suppression caused by medications or
human immunodeficiency virus; and pregnancy, including up to 6
weeks postpartum [6].
Qualitative (Interview) Data
One hundred twenty randomly selected patients who had been
hospitalized with pH1N1 during April 23, 2009–December 31,
2009 were mailed invitations to participate in telephone interviews
designed to investigate health seeking behavior related to their
hospitalization. Patients were stratified by IDPH immunization
region and race/ethnicity; patients who were not Illinois residents
were excluded. After stratification, patients were selected by
random sampling from each of the strata; the number of patients
selected from each stratum was proportional to representation in
the state. To improve representation of minorities in the interview,
non-Hispanic blacks and Hispanic patients were oversampled.
Letters of introduction were followed by telephone contact
approximately one week later. At least 2 telephone attempts were
made to contact all patients. All interviews were conducted during
April–June 2010.
Upon contact, oral consent to be interviewed was obtained. In
the event that the hospitalized individual was a minor child, a
parent was interviewed. The confidentiality of the respondents and
their responses was assured at the beginning of the interview. All
interviewers were trained to use a standardized script. The
interview included both closed- and open-ended questions.
Standardized probes were used to investigate symptoms, vaccina-
tion history, treatment history, access-to-health-care, insurance
coverage, presence or absence of primary care physicians, personal
perceptions, and cues to action for preventing influenza illness in
the future. The interviews were transcribed in real time by a 3–5
person interview team. If the interviewee only spoke Spanish, a bi-
lingual interview team re-contacted the individual and the
interview was conducted in Spanish. After all interviews were
completed, the transcripts were qualitatively coded for themes by
using an immersion and crystallization process and aggregated
into categories for analysis.
This investigation was conducted as part of public health
practice and was classified as non-research by the Chicago
Department of Public Health institutional review board and a
human subjects review coordinator at the Centers for Disease
Control and Prevention.
Statistical Analysis
Rates per 100,000 population were calculated by using the 2009
midyear population estimates published by the Census Bureau as
denominators [7]; rates were stratified by sex, race/ethnicity, and
age group. Rates were suppressed when the numerator count was
,5. Differences in proportions were evaluated using Pearson chi-
square or Fisher’s exact test. All reported p values were 2-sided,
and a p value of ,.05 was considered a statistically significant.
Quantitative analysis was completed using SASH, version 9.13
(SAS Institute, Inc., Cary, North Carolina).
Results
Quantitative (Surveillance) Analysis
A total of 2,824 pH1N1 hospital admissions were identified in
Illinois during April–December 2009 (Table 1). Hospital admis-
sions peaked during surveillance week 20 (May 2009) in the first
wave of the pandemic, and during surveillance week 43
(November 2009) in the second wave (Figure 1). Of the 2,824
identified admissions, 1,333 patients (47%) were male, median
(interquartile range [IQR]) age at admission was 23.7 years (range:
6–49). Among the 2,824 admissions, non-Hispanic whites
accounted for 1,068 (38%); blacks, 707 (25%); Hispanics, 680
(24%); Asian/Pacific Islanders, 107 (4%); Native Americans, 6
(0.2%); other, 63 (2%); and 193 (7%) were unknown. The median
(IQR) hospital length of stay (HLOS) was 2 (range: 1–4) days. Of
7,651 total inpatient days, whites accounted for 3,500 (46%) days;
blacks, 1,648 (22%) days; and Hispanics, 1,560 (20%) days.
Residents aged ,50 years accounted for 5,394 (71%) inpatient
days. Approximately half of the patients (1,439 [51%]) were
admitted into teaching hospitals, and 1,231 (44%) into community
hospitals. Information on hospital type was unknown for 154 (5%)
of hospital admissions. Of hospitalized patients, 324 (11%)
reported $1 medical co-morbidity; of these, $2 medical co-
morbidities were reported by 65 (20%) patients. The prevalence of
co-morbidities was higher for blacks (126 [18%] of 707) and
Hispanics (80 [12%] of 680), compared with that of whites (76
[7%] of 1,068). Compared with a hospitalization rate of 13/
100,000 (95% Confidence Interval [95%CI] 12–14) population for
whites, the hospitalization rate for blacks was 36 admissions/
100,000 population [95%CI, 33–39] (rate ratio, 3; p,0.001) and
for Hispanics was 35 admissions/100,000 population [95% CI,
32–37] (rate ratio, 2.6; p,0.001). There were 91 deaths, resulting
in a case fatality rate of 3%. Of these 91 deaths, 47 (52%) were
whites, 19 (21%) were Hispanics, 17 (19%) were blacks, 6 (7%)
were unknown, 1(1%) was Asian and 1(1%) was classified as other.
Mortality rates were higher for blacks (0.9/100,000; p,0.09) and
Hispanics (1/100,000; p,0.04) than whites (0.6/100,000)
(Table 2). Regardless of sex, hospitalization rates for blacks and
Hispanics, were significantly higher compared to whites (data not
shown).
State-wide hospitalization rates were inversely proportional to
age group, with hospital admission rates highest for children aged
,5 years and lowest for residents aged .65 years. For all age
groups, hospitalization rates were higher for blacks and Hispanics
than for whites (p,0.001). For persons aged $65 years, the
hospitalization rate for Hispanics (40 per 100,000 population;
[95% CI, 28–56]) was substantially greater than that for whites (8
per 100,000[95% CI, 6–9) or blacks (18 per 100,000[95%CI, 12–
25) p,0.001) (Table 3).When stratified by IDPH immunization
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regions, the cumulative hospitalization rates of varied by region,
with the Rockford (35 per 100,000 [95%CI, 31–40]) and Chicago
Cook (29 per 100,000[95%CI, 27–30]) regions reported the
highest rates and Edwardsville reported the lowest 7.3 per
100,000[95%CI, 6–9]).Similarly, for all racial and ethnic groups,
Rockford region had the highest hospital admission rates.
Severe clinical presentation requiring intensive care unit (ICU)
admission was reported by 421 of 2,824 (15%) patients. The
proportion of ICU to total admissions was higher for whites;
however, the proportion of patients admitted into the ICU who
reported $1 medical co-morbidity was lower for whites than for
other racial groups.
Qualitative (Interview) Analysis
Of the 120 Illinois residents randomly selected to participate in
the interview, phone contact was established with 60, of which 33
(55%) completed the interview. Among respondents, 13 (39%)
were white; 10 (30%) were black; and 10 (30%) were Hispanic; the
racial and ethnic distribution was similar to the overall random
sample (Table 1). One respondent was admitted to the hospital
during the first wave (Table 4). The median (IQR) age of
respondents was 31 years (range: 8–53); 19 (58%) respondents
were male.
After becoming sick, 15 (45%) respondents reported the use of
over-the-counter medication as a method of treatment. Other
responses included use of an inhaler or nebulizer, consulting with a
personal physician, use of antibiotics, drinking fluids, use of home
remedies, resting, taking a bath, use of a prescription or TamifluH
(Genentech, Inc., South San Francisco, California), and seeking
medical care at the hospital. Eight respondents reported that they
did not treat symptoms before seeking medical care at the hospital.
Nineteen respondents (58%) stated that they did not pursue any
other medical evaluation before seeking medical care at the
hospital. Eight (24%) respondents reported specific barriers that
delayed their decision to seek healthcare. The reported barriers
(number reporting them) are as follows: cost of care or lack of
healthcare coverage (1), no paid sick leave (1), missing work (1),
transportation (1), language or communication barrier (1), dislike
of hospitals and overcrowded emergency departments (1), no ideal
treatment (1), and not wanting to find a new doctor (1).
Of the 8 participants that reported a barrier the average time
from symptom onset to hospital admission was 2.69 days. Of those
Table 1. Demographics of residents hospitalized with 2009 influenza (A) H1N1 in Illinois, April–December, 2009.
Characteristic Value
No. of residents hospitalized 2,824
Male, no. (%)a 1,333 (47)
Median age, yrs (IQR)b 23.7 (6–49)
Admitted to ICUc, no. (%) 421 (15)
Reported $1medical co morbidity 324 (11)
Co morbidity prevalence, (number with $1 co morbidity/total admitted [%])
White 76/1,068 (7)
Black 126/707 (18)
Asian/Native Hawaiian/Pacific Islander 8/107 (7)




Received antiviral therapy, no. (%) 1,688 (60)
Median hospital length of stayc, days, (IQR)b 2 (1–4)
Total inpatient days 7,651
Pregnant, no. (%) 110 (3.9)
Age Group
,1 year, no. (%) 257 (9)
1–4 yrs, no. (%) 322 (11)
5–24 yrs, no. (%) 885 (31)
25–49 yrs, no. (%) 706 (25)
50–64 yrs, no. (%) 470 (17)
$65 yrs, no. (%) 184 (7)
Hospital type
Teaching hospital, no. (%) 1,439 (51)
Community hospital, no. (%) 1,231(44)
Unknown, No. (%) 154 (5)
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that reported no barriers to seeking healthcare (n = 23), the
average time from symptom onset to hospital admission was 1.89
days.
The median interval between onset of symptoms and seeking
initial treatment from a healthcare provider was 2 (range: 1–7)
days; this interval was similar for all racial/ethnic groups. The
median interval between onset of symptoms and hospital
admission was 4 days for both blacks and for Hispanics, compared
with 2 days for whites. When stratified by age group, race and
ethnicity there were differences in longest mean of interval
reported. For Whites, respondents aged between 5 and 24 years
reported the longest mean duration (4.3 days), Black respondents
aged 50–64 years reported longest mean duration of 6.5 days, and
Hispanics respondents aged 65 years and above reported the
longest mean duration (6.0 days).
The median (IQR) HLOS of the respondents was 2 days (range:
2–4.5); overall the mean HLOS was highest for blacks (3.8 days)
compared with White (3.0 days), and Hispanic (2.8 days). When
HLOS was stratified by age group and race, individuals aged 50–
64 years for all race and ethnic groups reported the longest mean
HLOS. Three (9%) of the respondents were admitted into the
ICU.
Among respondents, 31 (94%) stated that they had heard of
pH1N1 (also referred to as swine flu) before hospitalization
(Table 4). For each racial and ethnic group there were variations
in the proportions of age groups who had heard about H1N1. Of
those who had heard these terms, the news media was cited as
being the most common source (77%), followed by primary
healthcare provider (10%), workplace (10%), and from family or
friends (6%).
When asked about perception of risk, 24 (73%) stated that they
did not perceive themselves to be at risk for acquiring H1N1
before becoming sick (Table 4) because they were either not
around sick people or they rarely got sick. The proportion of
respondents who perceived themselves to be at risk was greater for
whites (6 [46%] of 13) than for blacks (2 [20%] of 10) or Hispanics
(1 [10%] of 10).
The main reason cited by respondents for not receiving the
vaccine was lack of availability. Of the 33 respondents, 29 were
hospitalized after mid October 2009 when the monovalent H1N1
vaccine became available; of these, 27 (93%) responded that they
did not receive the vaccine (Table 4). Twenty-nine (88%) reported
having some form of health insurance coverage. When asked
about usual source of healthcare, 27 (82%) respondents stated that
they most often go to their personal healthcare provider, 5 (15%)
said the emergency department, and 1 (3%) said a community
health clinic.
When asked how to prevent pH1N1 infection in the future, the
two most common responses were 1) get vaccinated and 2) practice
hand hygiene, both indicated by 15 (28%) of 53 total responses
received. One participant stated, ‘‘Make sure that everybody had
the shot. It almost took my life, and I can imagine what it can do to
somebody else’s.’’ At the conclusion of the interview, respondents
were asked what they wish they had known or what single piece of
advice they would give to someone else on the basis of their
experiences with pH1N1. Ten of 46 (22%) responses focused on
getting vaccinated, 5 of 46 (11%) focused on seeking medical
attention, and practicing hand hygiene, staying away from sick
people, and educating yourself and others were each mentioned 4
of 46 (9%) times.
Discussion
This study was a mixed methods analysis, using quantitative
(surveillance) hospital admission data and qualitative (interview)
data obtained from follow-up interviews of a sample of Illinois
residents who were hospitalized during April–December 2009.
Consistent with other studies [8–15], pH1N1 hospitalization and
Figure 1. Data of pandemic 2009 influenza A (H1N1) hospitalizations by race and ethnicity, Illinois April –December 2009.
doi:10.1371/journal.pone.0084380.g001
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mortality rates among blacks and Hispanics in Illinois were higher
than those for whites.
It is unclear whether the disparities in pH1N1 hospitalization
and mortality rates documented in our study and others are
attributable to differences in disease incidence, disparities of
underlying chronic conditions, or unequal access to healthcare
leading to differences in timely care-seeking behaviors [16].
Factors that have contributed to disparities in influenza incidence
among minorities during previous influenza seasons include lower
rates of vaccination coverage resulting in islands of susceptibility,
and differences in viral circulation among geographic regions [17–
21]. Previous studies have also attributed the increased risk for
Table 3. 2009 influenza A(H1N1) hospital admission rates/100,000 population by race/ethnicity and age group, Illinois, April–
December 2009.
Race/Ethnicity
Age group Whitea Black Hispanic Statewide P valueb
0–4 yrs Rates (95% C.I.)c 30 (25–35) 91(76–109) 90 (78–103) 61(56–66) ,0.001
5–24 yrs Rates (95% C.I.) 15 (14–17) 40 (35–46) 30 (26–35) 25 (24–27) ,0.001
25–64 yrs Rates (95% C.I.) 12 (11–13) 32 (28–36) 24 (21–27) 18 (17–19) ,0.001
$65 yrs Rates (95% C.I.) 8 (6–9) 18 (12–25) 40 (28–56) 12 (10–14) ,0.001
aReferent group.
bP value calculated chi-square test (Fisher’s exact or Pearson).
c95% Confidence Interval.
doi:10.1371/journal.pone.0084380.t003
Table 4. Qualitative demographical, clinical, and qualitative interview responses among 33 Illinois residents hospitalized with 2009
influenza A (H1N1) — April–December, 2009.
Characteristic Frequency No. (%)
Response rate 33/60 (55)
White 13/33 (39)
Male 19/33(58)
Admitted during 1st wave 1/33 (3)
Aged ,18 years 11/33 (33)
Admitted to ICUa 3/33 (9)
Mechanical ventilation 0/33 (0)
Antiviral therapy 21/33 (64)
Heard of H1N1 before hospitalization 31/33 (94)
Did not feel at risk for getting H1N1 24/33 (73)
Did not receive H1N1 vaccination 27/29 (93)
Lack of availability 15/27 (56)
Just did not 4/27 (15)
Side-effects 2/27 (7)
Doctor advice 1/27 (4)
Too young 1/27 (4)
Reaction to vaccine 1/27 (4)
Got sick before getting vaccine 1/27 (4)
Injectable form not available 1/27 (4)
Do not get vaccinations 1/27 (4)
Missed chance at work because of illness 1/27 (4)
Had health insurance at time of admission 29/31 (94)
Did not seek healthcare before admission 19/32 (59)
Rapid onset of symptoms 12/33 (36)
Used OTCb medications 15/33 (45)
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complications and mortality among minorities to the higher
burden of chronic diseases within these populations. In our study,
the prevalence of co-morbidities among patients hospitalized with
pH1N1 in Illinois was higher for blacks and Hispanics than for
whites. It has also been proposed that unequal access to healthcare
by minorities may lead to delays in treatment, thus contributing to
disparities in morbidity and mortality [9,22]. The small sample
size of our interview respondents precludes statistical comparison
however, although the time from symptom onset to seeking initial
healthcare was similar among racial/ethnic categories, the median
interval between onset of symptoms and hospitalization was longer
for blacks and Hispanics (4 days) than for whites (2 days).
Our finding that state-wide hospitalization rates were inversely
proportional to age group was similar to that of California [23].
The median age of Illinois residents hospitalized with pH1N1 was
24 years, similar to the median age of 25 years in California [23].
Reasons for the relative decrease in hospitalization rates for older
persons with pH1N1 are unclear. Though studies have confirmed
that pre-existing antibodies may have protected older persons from
pH1N1 infection, diminished cell-mediated immunity might have
contributed to greater severity after infection [24]. Though
hospitalization rates decreased with increasing age for whites
and blacks, this was not the case for Hispanics. Our study
documented an admission rate for Hispanics .65 years old that
was substantially higher than those for whites or blacks, and there
is no epidemiologic or clinical evidence suggesting that older
Hispanics in Illinois are more susceptible to pH1N1 by virtue of
ethnicity alone.
Policy makers and public health officials should develop and
promote culturally sensitive communication and health education
campaigns to improve vaccination rates and other methods of
prevention (e.g., social distancing, hand washing) among minor-
ities and hard to reach populations. Because of the higher
hospitalization rates among patients aged ,5 years, public health
authorities should improve access to vaccines, and employers
should explore ways to improve sick-leave and telework policies for
parents of ill children.
The low receipt of the pH1N1 vaccine among survey
respondents in our study is similar to results from the Behavioral
Risk Factor Surveillance System and the National 2009 H1N1 Flu
Survey. Specifically, these results demonstrated vaccine uptake
estimates in Illinois of 25.1% for all residents, 21.6% of residents
aged $18 years, and 37.5% of residents aged 6 months–17 years
[25]. When asked why they had not received the flu vaccine,
approximately half of our respondents cited non-availability.
Surveys in the United States before the availability of the
pH1N1vaccine reported that 40%–60% of U.S. adults intended
to receive the H1N1 vaccine when it became available [26–28].
Vaccination intentions for pH1N1 were strongly associated with
seasonal influenza vaccinations, indicating common attitudinal
barriers to both vaccines [26]. Assuming a constant vaccine
supply, future studies should explore the relationship between a
willingness to receive the vaccine, and actually obtaining it.
Severe disease from pH1N1 infection has been associated with a
longer interval from onset of symptoms to treatment with antiviral
therapy, and with the presence of underlying co-morbidities [29–
32] In our study, interview respondents reported delays (median, 2
days) between onset of symptoms and decision to seek care; this
did not change when adjusted for ICU admission. Of 33
respondents, 12 (36%) reported that rapidity of symptom onset
was the reason for seeking medical care. A majority of respondents
did not report inadequate access to care, lack of a medical home,
or lack of insurance as barriers to receiving healthcare.
Certain respondents agreed that vaccination, early medical
care, hand hygiene, and social distancing were important
preventive methods for the future.
Knowledge has a considerable influence on attitudes and
practices during a pandemic, and personal experience influences
behaviors. A person’s response to the threat of disease is dependent
on perception of risk, which itself is influenced by public and
private information disseminated by the media [33]. Although
31of the 33 (93%) interview respondents had heard about pH1N1
in the news, indicating the importance of mass media as an
information source, 24 of the 33 respondents (72%) felt they were
not at risk of being infected. The relatively low level of mortality
reported during this pandemic and its influence on risk perception
and vaccine seeking behavior [34], should be evaluated. When
levels of worry are low, acting to increase the volume of mass
media and advertising coverage is likely to increase the perceived
efficacy of recommended behaviors and in turn likely to increase
the uptake of recommended preventive measures [35]. Shortcom-
ings in educational outreach might have been a factor in our
respondents’ understanding of their risk for infection. Therefore,
efforts should be targeted at educating the general population to
improve practices for future epidemics [36].
Racial/ethnic minority populations have higher hospitalization
and mortality rates, and poorer health outcomes for pH1N1, and
other diseases, than do whites [15,18,37–39]. Pandemic prepared-
ness and response can be improved by 1) developing culturally and
linguistically sensitive communication plans that address the
specific needs of minority communities, 2) enhancing health
system safety nets, and 3) developing social policies that minimize
economic burdens and improve compliance with isolation and
quarantine, [40].
One limitation of our study was that we did not validate I-
NEDSS surveillance data regarding hospitalizations or co-
morbidities with medical records abstraction. As a result, we were
unable to assess factors relating to insurance type, education level
or household size; such information may have informed us about
the influence of socioeconomic circumstances on health. Also,
because height and weight information were not available, we
could not assess the association between obesity and severity of
illness that has been established in previous studies. Regarding co-
morbidities, previous studies have reported that 62–73% of
hospitalized patients presented with an underlying medical
condition [23,41,42]. Our reporting that 11% of hospitalized
patients had underlying medical conditions likely reflects an
underreporting of co-morbidities into I-NEDSS.
False-negative test results, lack of testing due to a low clinical
index of disease suspicion, and the belief that testing was not
essentially for management of patients may have contributed to an
undercounting of the true burden of pH1N1 in hospitalized
patients. Because interviews were conducted months after
hospitalization, study respondents might not have recalled details
of events surrounding hospitalization. Finally, interviews were
conducted among a sample of only 33 Illinois residents hospital-
ized for pH1N1. Consequently, our study was underpowered to
assess differences among racial/ethnic groups, and our findings
might not be representative of all pH1N1-infected residents who
were hospitalized. Despite these limitations, these data provide
insight into perceptions of patients infected and hospitalized with
pH1N1.
Future pandemic mitigation strategies should include commu-
nication methods that address risk perception (targeted to hard-to-
reach communities, including minorities). We recommend pre-
ventive measures that emphasize the provision and early access to
antiviral medications and vaccines [1,43,44].
Disparities among 2009 H1N1 Hospital Admissions
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